Protease inhibitor therapy for HIV infection: The effect on HIV-associated nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 14, Issue 3, 1999, Pages 744-747

  Dellow, Emma ^a   Unwin, Robert ^a,b   Miller, Robert ^a   Williams, Ian ^a   Griffiths, Meryl ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

HIV infection; Nephrotic syndrome; Protease inhibitor

Indexed keywords

PROTEINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL;

EID: 0033041423     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.3.744     Document Type: Article

References (19)

1. Seney FD, Burns DK, Silva FG. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990; 16: 1-13
2. Connolly JO, Weston CE, Hendry BM. HIV-associated renal disease in London hospitals. Q J Med 1995; 88: 627-634
3. Mattana J, Siegal FP, Schwartzwald E et al. AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone. Am J Kidney Dis 1997; 30: 116-119
4. Nochy D, Glotz D, Dosquet P et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993; 8: 11-19
5. Jindal KK, Trillo A, Bishop G et al. Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol 1991; 11: 147-150
6. Stokes MB, Chawla H, Brody RI, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997; 29: 514-525
7. Watterson MK, Detwiler RK, Bolin P. Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 1997; 29: 624-626
8. Michel C, Dosquet P, Ronco P et al. Nephropathy associated with infection with human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine. Nephron 1992; 62: 434-440
9. Williams DI, Williams DJ, Williams IG et al. Presentation, pathology and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm Inf 1998; 74: 179-184
10. Green DF, Resnick L, Bourgoignic JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 1992; 41: 956-960
11. Shukla RR, Kumar A, Kimmel PL. Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 1993; 44: 1022-1029
12. Kekow J, Wachsman W, McCuthan A et al. Transforming growth factor beta and non-cytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1990; 87: 8321-8325
13. Kimmel PL, VedBrat SS, Pierce PF et al. Prevalence of viraemía in human immunodeficiency virus-infected patients with renal disease. Arch Intern Med 1995; 155: 1578-1584
14. Gazzard B, Moyle G. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998; 352: 314-316
15. Henry K, Melroe H, Huebsch J et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998; 351: 1328
16. Carr A, Samaras K, Burton S et al. A syndrome of peripheral lipodystrophy and insulin resistance in patients receiving protease inhibitors. ADIS 1998; 12: F51-F58
17. Miller KD, Jones E, Yanovski JA et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-875
18. Lo JC, Mulligan K, Tai VW. 'Buffalo hump' in men with HIV-1 infection. Lancet 1998; 351: 867-870
19. Berns JS, Cohen RM, Silverman M et al. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases. Am J Kidney Dis 1997; 30: 558-560